NIH Hydroxyurea Treatment For Sickle Cell Disease Conference, Feb. 25-27
For many patients, the pain and complications associated with sickle cell disease can have a profound affect on their quality of life, ability to work, and long-term health and well-being. Unfortunately, these challenges are often coupled with meaningful barriers to care. Hydroxyurea is an FDA-approved therapy for adults with convinced forms of sickle cell disease, and acts to increase the percentage of non-sickled red blood cells in circulation.
Original post by Dentistry News From Medical News Today
Related Articles
Red Cell Substitute May Work Against Sickle Cell Disease Give The Gift Of Life During Sickle Cell Anemia Awareness Month Risk Of Death Can Now Be Predicted In Sickle Cell Disease Sickle Cell Disease Pain Prevalence And Severity Higher Than preceding Estimates [Includes Video] Sickle Cell Patients Treated Safely With Anticlotting Drug
No comments yet. Be the first.
Leave a reply
